It is with great pleasure that we announce that Equashil, a leading innovator in Closed System Transfer Devices (CSTDs) and automated compounding solutions, has launched its latest product, the Mundus Mini HD. In this state-of-the-art solution, EQUASHIELD's unwavering commitment to safety, quality, and efficiency is combined with breakthrough technology in order to revolutionize the landscape of automated pharmacy compounding of hazardous drugs.
Introducing the Next Generation in Safe, Efficient, and High-Quality Automated Compounding of Hazardous Drugs.
In the field of automated compounding of hazardous drugs, the Mundus Mini HD is designed to become a major breakthrough. With the help of the unique CSTD of EQUASHIELD, this compact and powerful solution ensures the utmost safety in handling hazardous drugs while reducing the chances of contamination, exposure, and medication errors.
In terms of automated compounding of hazardous drugs, Mundus Mini HD represents an important breakthrough in the field. Using EQUASHIELD's unique CSTD, this compact yet powerful solution ensures the highest level of safety as it handles hazardous drugs, reducing the risk of contamination, exposure, and medication errors while ensuring the utmost safety.
 Mundus Mini HD is designed with safety and quality at its core, offering improved traceability, reporting, and dose accuracy verification through the use of three embedded cameras, machine vision, and artificial intelligence technology.. Combining these two powerful factors significantly lowers the possibility of errors attributable to the compounding process, such as incorrect medication, diluent, dosage amount, and labeling errors. As a result of its streamlined workflow management, it enhances efficiency and significantly decreases medication errors, making the compounding process a safer and more efficient one
As a result of its streamlined workflow management, it enhances efficiency and significantly decreases medication errors, making the compounding process a safer and more efficient one

Source prnewswire